Geron shares soared Friday after the Food and Drug Administration approved the company's drug Rytelo for patients with rare blood cancers who are suffering from anemia.
Geron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call Transcript May 2, 2024 Geron Corporation beats earnings expectations. Reported EPS is $-0.09178, expectations were $-0.1. Geron Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My name […]
These 2 Ventura County spots may soon get national recognition as historic places. Here's why yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Health: US FDA staff raises concerns on Geron's blood disorder drug gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.